1005206-12-1

Basic information

• Product Name: 1,1-dimethyl-2-[2-[2-[[4-(methylthio)phenyl]amino]isonicotinoyl]hydrazino]-2-oxoethyl acetate
• Synonyms: 1,1-dimethyl-2-[2-[2-[[4-(methylthio)phenyl]amino]isonicotinoyl]hydrazino]-2-oxoethyl acetate
• CAS NO: 1005206-12-1
• Molecular Weight: 402.474
• Mol File: 1005206-12-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 1,1-dimethyl-2-[2-[2-[[4-(methylthio)phenyl]amino]isonicotinoyl]hydrazino]-2-oxoethyl acetate(CAS DataBase Reference)
• NIST Chemistry Reference: 1,1-dimethyl-2-[2-[2-[[4-(methylthio)phenyl]amino]isonicotinoyl]hydrazino]-2-oxoethyl acetate(1005206-12-1)
• EPA Substance Registry System: 1,1-dimethyl-2-[2-[2-[[4-(methylthio)phenyl]amino]isonicotinoyl]hydrazino]-2-oxoethyl acetate(1005206-12-1)

Safety Data

• Hazardous Substances Data: 1005206-12-1(Hazardous Substances Data)

Upstream product

• 1005206-09-6 2-[[4-(methylthio)phenyl]amino]isonicotinohydrazide 
• 40635-66-3 2-acetoxy-2-methylpropanoyl chloride 

Downstream Products

• 1005202-48-1 1-methyl-1-[5-[2-[[4-(methylthio)phenyl]amino]-4-pyridyl]-1,3,4-oxadiazol-2-yl]ethyl acetate 

Relevant articles and documents

GSK-3BETAINHIBITOR

For the purpose of providing a GSK-3β inhibitor containing an oxadiazole compound or a salt thereof or a prodrug thereof useful as an agent for the prophylaxis or treatment of a GSK-3β-related pathology or disease, the present invention provides a GSK-3β inhibitor containing a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof or a prodrug thereof.